Market news
BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
NewMediaWire Press Release.
(Updates with the latest stock price in the headline and last paragraph.) Beta Bionics (BBNX) rep
NewMediaWire Press Release.
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
NewMediaWire Press Release.
NewMediaWire Press Release.
BBNX's FDA-cleared Mint patch pump expands its diabetes portfolio, with a full U.S. launch planned for the first quarter of 2027.
NewMediaWire Press Release.
Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Beta Bionics (BBNX) has an average rating of overweight and mean price target of $22.40, according t
Beta Bionics priced an underwritten public offering of about 7.7 million shares at $17.25 per share
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per share, which equals the public offering price per share of the common stock less the $0.0001 exercise pri
Beta Bionics (BBNX) said late Tuesday it launched an underwritten public offering of $125 million of
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
Beta Bionics (BBNX) has an average rating of overweight and mean price target of $20.31, according t
Senseonics (SENS) has partnered with Beta Bionics (BBNX) to integrate its Eversense 365 continuous g
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.